Clinical Trials Sponsored by Hangzhou Valgen Medtech Co., Ltd

Total 634 results

Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease

China
Hangzhou Valgen Medtech Co., Ltd

Recruiting

Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Hangzhou Valgen Medtech Co., Ltd

Active, not recruiting

Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy

Obstructive Hypertrophic Cardiomyopathy

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation

Tricuspid Regurgitation

China
Hangzhou Valgen Medtech Co., Ltd

Not yet recruiting

DragonFly EU Pivotal Study

Mitral Valve Insufficiency
Hangzhou Valgen Medtech Co., Ltd

Recruiting

Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation

Mitral Regurgitation Functional

China
Hangzhou Valgen Medtech Co., Ltd

Enrolling by invitation

Dragonfly-M Early Feasibility Study

Mitral Regurgitation

China
Hangzhou Valgen Medtech Co., Ltd

Unknown

Safety and Performance Study of the MitralStitch Repair System.

Mitral Regurgitation

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's False Lumen Embolization : The First in Man Study of WeFlow-EndoSeal Aorta Vascular Plug System

Aortic Dissection Aneurysm

China
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real World Study on Fabulous® Thoracic Aortic Stent System for Stanford B Aortic Dissection

Aortic Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Safety and Efficacy Study of WeFlow-JAAA Stent Graft System for Complex Abdominal Aortic Aneurysm(GREAT Study)

Juxtarenal Abdominal Aortic Aneurysm

China
Hangzhou Endonom Medtech Co., Ltd.

Active, not recruiting

Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

Type B Aortic Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Active, not recruiting

Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System

Aortic Arch; Aneurysm, Dissecting

China
Hangzhou Endonom Medtech Co., Ltd.

Unknown

Guo's Visceral Arteries Reconstruction :The First in Man Study of WeFlow-JAAA Stent Graft System

Juxta Renal Abdominal Aortic Aneurysm Without Rupture

China
Hangzhou Endonom Medtech Co., Ltd.

Not yet recruiting

A Real-World Study on Distal Aortic Remodeling for Stanford Type B Aortic Dissection With Fabulous Thoracic Aortic Stent System

Aortic Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Endovascular Aortic Arch Replacement of Aortic Dissection by WeFlow-Tribranch Endoprothesis: a Multicenter Pilot Study(GRAFT Study)

Aortic Aneurysm and Dissection

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Aortic Arch Reconstruction :The Prospective ,Multiple Center Study About the Safety and Efficacy of WeFlow-Arch Modeler Embedded Branch Stent Graft System (GIANT Study)

Aortic Arch Aneurysm

China
Hangzhou Endonom Medtech Co., Ltd.

Recruiting

Guo's Entry Tear Repair :The First in Man Study of Endopatch System

Chronic Stanford B Type Aortic Dissection Proximal Tear

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Treatment of Vein Stenosis or Occlusion With the Oblique Stent

Iliac Vein Stenosis | Iliac Vein Occlusion

China
Hangzhou Endonom Medtech Co., Ltd.

Completed

Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection

Aortic Dissection Type B

China
Hangzhou NOYA MedTech Co. Ltm.

Recruiting

NoYA RAISE Trial II (Radiofrequency Ablation-Based Interatrial Shunt for Heart Failure)

Heart Failure

China
Venus MedTech (HangZhou) Inc.
Core Medical (Beijing) Co., Ltd.

Unknown

Efficacy and Safety of Venus P-valve to Treat RVOT Stenosis With Pulmonary Regurgitation

Right Ventricular Outflow Tract Stenosis

China
Medtecx Co Ltd.

Completed

Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms

Overactive Bladder

China
Hangzhou Endonom Medtech Co., Ltd.
Wayne W.Zhang , Seattle，Washington，USA

Recruiting

Percutaneous Endovascular Arch Repair Trial (PEART) Study

Aortic Diseases

China
Hangzhou Converd Co., Ltd.

Recruiting

Safety of Recombinant Human IL-21 Oncolytic Vaccinia Virus Injection（hV01) in Advanced Tumors

Advanced Solid Tumors

China
HJB (Hangzhou) Co., Ltd.

Recruiting

TST002 Intervenous Injection in Postmenopausal Women and Men With Reduced Bone Mineral Density

Osteoporosis

China
CHA MEDITECH Co., Ltd.

Completed

Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement

Penile Enhancement | Small Penis

Korea, Republic of
Jiangsu CED Medtech Co., Ltd

Not yet recruiting

The Flow Diverter for Treating Patients With Intracranial Aneurysms

Intracranial Aneurysm
Fuda Cancer Hospital, Guangzhou
Shanghai Asclepius Meditech Co., Ltd

Completed

Hydrogen Gas for Cancer Rehabilitation

Adult Solid Tumor

China
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
Hangzhou Adcoris Biopharmacy Co., Ltd

Not yet recruiting

Study of ACR246 in Advanced Solid Tumors

Advanced Solid Tumors
Hangzhou DAC Biotechnology Co., Ltd.

Not yet recruiting

A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies

Advanced Solid Tumors | Hematological Malignancies
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2918 For Advanced Malignant Tumors

Advanced Malignant Tumors

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus (SLE)

China
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Recruiting

A First-in-human of Multiplle Doses of BB-1705 in Subjects With Locally Advanced/Metastatic Solid Tumors

Solid Tumor

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Chronic Spontaneous Urticaria

China
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.

Completed

Study of WPV01 in Healthy Subjects

Healthy Participants

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Moderate to Severe Plaque Psoriasis

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

The Safety and Efficacy of TLL-018 in Active Rheumatoid Arthritis

Rheumatoid Arthritis

China
Hangzhou Sciwind Biosciences Co., Ltd.

Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients

Type 2 Diabetes Mellitus | T2DM

China
Hangzhou Zenshine Pharmaceuticals Co., Ltd.

Terminated

Dose-Escalation and Dose-Expansion Study of ZX-101A in Patients With Relapsed/Resistant or Refractory Advanced Hematologic Malignancies

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Non-hodgkin Lymphoma

United States
Hangzhou Sciwind Biosciences Co., Ltd.

Recruiting

A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin

Healthy Volunteers

China
Hangzhou Highlightll Pharmaceutical Co., Ltd

Recruiting

A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs (TARA)

Rheumatoid Arthritis

China
Hangzhou Broncus Medical Co., Ltd.

Recruiting

Evaluation of Safety and Effectiveness of TLD Radiofrequency Ablation in the Treatment of COPD

COPD

China
Hangzhou Sumgen Biotech Co., Ltd.

Recruiting

SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma.

Lymphoma | Hematological Malignancy

United States
Hangzhou Highlightll Pharmaceutical Co., Ltd

Completed

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

Atopic Dermatitis

China
Hangzhou Broncus Medical Co., Ltd.

Completed

Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors (BRONC-RFⅡ)

Lung Neoplasms | Pulmonary Metastasis

China
Bliss Biopharmaceutical (Hangzhou) Co., Ltd

Active, not recruiting

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

Locally Advanced/Metastatic HER2 Positive Solid Tumors

China, United States

Clinical Trials Sponsored by Hangzhou Valgen Medtech Co., Ltd

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations